Walgreens Boots Alliance (NASDAQ:WBA) Updates FY 2024 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 2.800-2.950 for the period, compared to the consensus earnings per share estimate of 3.200. The company issued revenue guidance of -. Walgreens Boots Alliance also updated its FY24 guidance to $2.80-$2.95 EPS.

Analyst Ratings Changes

Several research firms recently weighed in on WBA. TD Cowen decreased their target price on Walgreens Boots Alliance from $37.00 to $35.00 and set a buy rating for the company in a research note on Wednesday, April 3rd. Raymond James restated a market perform rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft decreased their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a hold rating for the company in a research note on Wednesday, April 3rd. Bank of America restated an underperform rating and set a $11.00 target price (down previously from $22.00) on shares of Walgreens Boots Alliance in a research note on Friday. Finally, UBS Group decreased their target price on Walgreens Boots Alliance from $22.00 to $17.00 and set a neutral rating for the company in a research note on Monday, June 24th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Hold and an average price target of $20.64.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $12.10 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.32. The stock’s 50 day simple moving average is $16.49 and its 200-day simple moving average is $20.19. Walgreens Boots Alliance has a 12-month low of $11.68 and a 12-month high of $31.32.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.04). The company had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.00 EPS. As a group, analysts expect that Walgreens Boots Alliance will post 2.88 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were paid a $0.25 dividend. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.27%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.84%.

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The stock was acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. Company insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.